HDL and ASCVD

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2022 May 16

PMID 35575924

Authors

Hongtu Cui

Qian Du

Affiliations

Soon will be listed here.

Abstract

In this chapter, we summarize the relationship between circulating high-density lipoprotein (HDL) and atherosclerotic cardiovascular disease (ASCVD). HDL acts in many types of cells, such as endothelial cell, macrophage, T lymphocyte, etc. Recently, novel HDL-related therapies have been developed to treat ASCVD.

Citing Articles

High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?.

Liu K, Cooper M, Chai Z, Liu F Int J Mol Sci. 2025; 26(4).

PMID: 40004147 PMC: 11855193. DOI: 10.3390/ijms26041683.

References

Natarajan P, Collier T, Jin Z, Lyass A, Li Y, Ibrahim N . Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death. J Am Coll Cardiol. 2019; 73(17):2135-2145. PMC: 6501819. DOI: 10.1016/j.jacc.2019.01.073. View

Janoudi A, Shamoun F, Kalavakunta J, Abela G . Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque. Eur Heart J. 2015; 37(25):1959-67. DOI: 10.1093/eurheartj/ehv653. View

Choi H, Ruel I, Malina A, Garrod D, Oda M, Pelletier J . Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis. Eur Heart J. 2017; 39(14):1194-1202. DOI: 10.1093/eurheartj/ehx340. View

Berbee J, Boon M, Khedoe P, Bartelt A, Schlein C, Worthmann A . Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat Commun. 2015; 6:6356. PMC: 4366535. DOI: 10.1038/ncomms7356. View

Bartelt A, John C, Schaltenberg N, Berbee J, Worthmann A, Cherradi M . Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport. Nat Commun. 2017; 8:15010. PMC: 5399294. DOI: 10.1038/ncomms15010. View

Maganto-Garcia E, Tarrio M, Grabie N, Bu D, Lichtman A . Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation. 2011; 124(2):185-95. PMC: 3145407. DOI: 10.1161/CIRCULATIONAHA.110.006411. View

Gotsman I, Grabie N, Gupta R, DaCosta R, MacConmara M, Lederer J . Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation. 2006; 114(19):2047-55. DOI: 10.1161/CIRCULATIONAHA.106.633263. View

Gaddis D, Padgett L, Wu R, McSkimming C, Romines V, Taylor A . Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun. 2018; 9(1):1095. PMC: 5854619. DOI: 10.1038/s41467-018-03493-5. View

Kootte R, Smits L, van der Valk F, Dasseux J, Keyserling C, Barbaras R . Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA. J Lipid Res. 2015; 56(3):703-712. PMC: 4340317. DOI: 10.1194/jlr.M055665. View

10.

Hovingh G, Smits L, Stefanutti C, Soran H, Kwok S, de Graaf J . The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study. Am Heart J. 2015; 169(5):736-742.e1. DOI: 10.1016/j.ahj.2015.01.008. View

11.

Nicholls S, Andrews J, Kastelein J, Merkely B, Nissen S, Ray K . Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized.... JAMA Cardiol. 2018; 3(9):815-822. PMC: 6233644. DOI: 10.1001/jamacardio.2018.2121. View

12.

Du X, Kim M, Hou L, Le Goff W, Chapman M, Van Eck M . HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Circ Res. 2015; 116(7):1133-42. DOI: 10.1161/CIRCRESAHA.116.305485. View

13.

Vergeer M, Korporaal S, Franssen R, Meurs I, Out R, Hovingh G . Genetic variant of the scavenger receptor BI in humans. N Engl J Med. 2011; 364(2):136-45. DOI: 10.1056/NEJMoa0907687. View

14.

Hoekstra M, van der Sluis R, Hildebrand R, Lammers B, Zhao Y, Pratico D . Disruption of Phospholipid Transfer Protein-Mediated High-Density Lipoprotein Maturation Reduces Scavenger Receptor BI Deficiency-Driven Atherosclerosis Susceptibility Despite Unexpected Metabolic Complications. Arterioscler Thromb Vasc Biol. 2020; 40(3):611-623. DOI: 10.1161/ATVBAHA.119.313862. View

15.

Zheng L, Nukuna B, Brennan M, Sun M, Goormastic M, Settle M . Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest. 2004; 114(4):529-41. PMC: 503769. DOI: 10.1172/JCI21109. View

16.

Zheng L, Settle M, Brubaker G, Schmitt D, Hazen S, Smith J . Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. J Biol Chem. 2004; 280(1):38-47. DOI: 10.1074/jbc.M407019200. View

17.

Undurti A, Huang Y, Lupica J, Smith J, DiDonato J, Hazen S . Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J Biol Chem. 2009; 284(45):30825-35. PMC: 2781481. DOI: 10.1074/jbc.M109.047605. View

18.

Wu Z, Wagner M, Zheng L, Parks J, Shy 3rd J, Smith J . The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction. Nat Struct Mol Biol. 2007; 14(9):861-8. DOI: 10.1038/nsmb1284. View

19.

DiDonato J, Huang Y, Aulak K, Even-Or O, Gerstenecker G, Gogonea V . Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma. Circulation. 2013; 128(15):1644-55. PMC: 3882895. DOI: 10.1161/CIRCULATIONAHA.113.002624. View

20.

Hewing B, Parathath S, Barrett T, Chung W, Astudillo Y, Hamada T . Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2014; 34(4):779-89. PMC: 3966977. DOI: 10.1161/ATVBAHA.113.303044. View